Clinical trial
The Effect of Ribose on B-Type Natriuretic Peptide Levels in Congestive Heart Failure Patients
NCT00329485 is registered in ClinicalTrials.gov with Valen Labs as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Ribose on B-Type Natriuretic Peptide Levels in Congestive Heart Failure Patients
- Lead sponsor
- Valen Labs
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 30, 2006
- Completion date
- July 31, 2007
- Enrollment
- 120
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congestive heart failure